ctrl K

Zenas BioPharma Inc. (ZBIO)

NASDAQ: ZBIO · Real-Time Price · USD

12.00

0.44 (3.81%)

At close: May 02, 2025, 3:34 PM

Zenas BioPharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	5M	50M	n/a
Cost of Revenue	n/a	n/a	n/a
Gross Profit	5M	50M	n/a
Operating Income	-163.89M	-37.15M	-76.2M
Interest Income	n/a	n/a	n/a
Pretax Income	-156.56M	-36.82M	-119.28M
Net Income	-156.13M	-37.12M	-119.28M
Selling & General & Admin	29.75M	17.11M	13.51M
Research & Development	139.14M	60.03M	61.69M
Other Expenses	n/a	10M	1M
Operating Expenses	168.89M	87.15M	76.2M
Interest Expense	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a
Cost & Expenses	168.89M	87.15M	76.2M
Income Tax Expense	-429K	301K	n/a
Shares Outstanding (Basic)	41.79M	38.32M	38.32M
Shares Outstanding (Diluted)	41.79M	38.32M	38.32M
EPS (Basic)	-3.76	-0.97	-3.11
EPS (Diluted)	-3.76	-0.97	-3.11
EBITDA	-163.89M	-27.03M	-75.12M
EBIT	-163.89M	-27.15M	-75.2M
Depreciation & Amortization	n/a	113K	78K